Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

972
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
972
Tumor Immunotherapy01:27

Tumor Immunotherapy

1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Equivalent Patient-Reported Outcomes for Suture Staple Technique Versus Control Side-To-Side Endoscopic Gluteus Medius Repair.

Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association·2026
Same author

Three-dimensional distal humerus morphometry using an axis-constrained reference framework: Sexual dimorphism and articular scaling.

Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft·2026
Same author

Epidemiological trends of non-small cell lung cancer and systemic treatment rates as part of initial therapeutic strategy from 2016 to 2020 in Greece: results of the epidemiological part of INFINITY study.

BMC cancer·2026
Same author

Magnetic resonance imaging-based identification of the knee anterolateral ligament: A systematic review with meta-analysis.

Journal of experimental orthopaedics·2026
Same author

Coexistence of Tripartite Accessory Navicular Bone and Os Subfibulare.

Diagnostics (Basel, Switzerland)·2026
Same author

Avascular Necrosis of the Femoral Head Following Posterior Hip Dislocation in an Adolescent.

Journal of musculoskeletal & neuronal interactions·2026

Related Experiment Video

Updated: Jan 16, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

10.1K

Individualized mRNA Vaccines in Melanoma-Where Do We Stand?

Ioanna Gazouli1, Dimitrios Bafaloukos1, Christos Koutserimpas2

  • 1Medical Oncology Department, Metropolitan Hospital, Neon Faliron, 18547 Athens, Greece.

Vaccines
|September 27, 2025
PubMed
Summary

Personalized mRNA vaccines are an advanced immunotherapy for melanoma, offering tailored treatments. Further research is needed to fully understand their mechanisms and delivery for optimal patient outcomes.

Keywords:
antigen presentationimmunotherapyindividualized neoantigen treatmentlipid nanoparticlesmRNA vaccinemelanoma

More Related Videos

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.9K
A Melanoma Patient-Derived Xenograft Model
07:07

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

13.1K

Related Experiment Videos

Last Updated: Jan 16, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

10.1K
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.9K
A Melanoma Patient-Derived Xenograft Model
07:07

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

13.1K

Area of Science:

  • Oncology
  • Immunology
  • Biotechnology

Background:

  • Immunotherapy, particularly immune checkpoint inhibitors, has been a cornerstone in melanoma treatment for over a decade.
  • The emergence of personalized mRNA vaccines signifies a new frontier in cancer therapy, leveraging recent scientific advancements.

Purpose of the Study:

  • To highlight personalized mRNA vaccines as the next evolutionary step in melanoma treatment.
  • To underscore the growing body of clinical and preclinical data supporting mRNA vaccine research.
  • To identify key areas requiring further investigation for mRNA vaccine development.

Main Methods:

  • Review of current clinical and preclinical data on mRNA vaccines for melanoma.
  • Analysis of the potential mechanisms of action for mRNA vaccines.
  • Assessment of challenges related to immune cell interaction and delivery.

Main Results:

  • Immunotherapy, including immune checkpoint inhibitors, has a proven track record in melanoma treatment.
  • Emerging data on mRNA vaccines show promise and generate enthusiasm in the medical community.
  • Significant knowledge gaps persist regarding mRNA vaccine efficacy and delivery.

Conclusions:

  • Personalized mRNA vaccines represent a promising, tailored approach to melanoma treatment.
  • Continued research is crucial to elucidate mRNA vaccine mechanisms, immune effects, and delivery systems.
  • Addressing these unknowns will be vital for the successful clinical implementation of mRNA vaccines in melanoma therapy.